{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:56:22Z","timestamp":1793418982589,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pharma.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:16:45Z","timestamp":1785453405000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A highly-sensitive and selective LC\u2013MS\/MS platform for quantitative determination of diosgenin in mice plasma with comprehensive bioanalytical validation and pharmacokinetic study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2383-1677","authenticated-orcid":false,"given":"Hrishikesh","family":"Khude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-6729","authenticated-orcid":false,"given":"Rohan","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-7645","authenticated-orcid":false,"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.07.008_bib0145","doi-asserted-by":"crossref","first-page":"1035441","DOI":"10.1155\/2022\/1035441","article-title":"Diosgenin: an updated pharmacological review and therapeutic perspectives","volume":"2022","author":"Semwal","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2026.07.008_bib0150","doi-asserted-by":"crossref","first-page":"100170","DOI":"10.1016\/j.focha.2022.100170","article-title":"Diosgenin: chemistry, extraction, quantification and health benefits","volume":"2","author":"Arya","year":"2023","journal-title":"Food Chem Adv"},{"key":"10.1016\/j.pharma.2026.07.008_bib0155","doi-asserted-by":"crossref","first-page":"105573","DOI":"10.1016\/j.jsbmb.2019.105573","article-title":"Synthesis and anti-tumour, immunomodulating activity of diosgenin and tigogenin conjugates","volume":"198","author":"Michalak","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharma.2026.07.008_bib0160","doi-asserted-by":"crossref","first-page":"118182","DOI":"10.1016\/j.lfs.2020.118182","article-title":"Diosgenin, a steroidal saponin, and its analogs: effective therapies against different chronic diseases","volume":"260","author":"Dey","year":"2020","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.pharma.2026.07.008_bib0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3724\/SP.J.1009.2013.00608","article-title":"Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-\u03baB, Akt, and MAPK signaling pathways","volume":"11","author":"Yang","year":"2013","journal-title":"Chin J Nat Med"},{"issue":"2","key":"10.1016\/j.pharma.2026.07.008_bib0170","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10787-025-02102-4","article-title":"Diosgenin-mediated NF-\u03baB and MAPK pathway modulation for osteoarthritis treatment: molecular mechanisms, bioavailability enhancement, and therapeutic applications","volume":"34","author":"Adarkar","year":"2026","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharma.2026.07.008_bib0175","doi-asserted-by":"crossref","first-page":"3153082","DOI":"10.1155\/2020\/3153082","article-title":"Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances","volume":"2020","author":"Cai","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.pharma.2026.07.008_bib0180","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/molecules28062878","article-title":"Dioscorea spp.: bioactive compounds and potential for the treatment of inflammatory and metabolic diseases","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharma.2026.07.008_bib0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1248\/bpb.b12-00467","article-title":"Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration","volume":"36","author":"Okawara","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.pharma.2026.07.008_bib0190","article-title":"Diosgenin as a novel therapeutic natural product for various diseases: an overview","volume":"23","author":"Mohammed","year":"2023","journal-title":"J Nat Remedies"},{"key":"10.1016\/j.pharma.2026.07.008_bib0195","doi-asserted-by":"crossref","first-page":"629272","DOI":"10.3389\/fphar.2021.629272","article-title":"Pharmacokinetic profile and oral bioavailability of diosgenin, charantin, and hydroxychalcone from a polyherbal formulation","volume":"12","author":"Salunkhe","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.07.008_bib0200","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.2147\/DMSO.S326054","article-title":"The effects of diosgenin on hypolipidemia and its underlying mechanism: a review","volume":"14","author":"Sun","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.pharma.2026.07.008_bib0205","doi-asserted-by":"crossref","first-page":"127816","DOI":"10.1016\/j.bmcl.2021.127816","article-title":"Diosgenin-induced physicochemical effects on phospholipid bilayers in comparison with cholesterol","volume":"36","author":"Ondevilla","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.pharma.2026.07.008_bib0210","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/foods13111714","article-title":"Recent advances in sample preparation and chromatographic\/mass spectrometric techniques for detecting polycyclic aromatic hydrocarbons in edible oils: 2010 to present","volume":"13","author":"Gao","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.pharma.2026.07.008_bib0215","series-title":"ICH M10: bioanalytical method validation and study sample analysis","author":"Agency","year":"2022"},{"key":"10.1016\/j.pharma.2026.07.008_bib0220","doi-asserted-by":"crossref","first-page":"4156293","DOI":"10.1155\/2016\/4156293","article-title":"Diosgenin: recent highlights on pharmacology and analytical methodology","volume":"2016","author":"Jesus","year":"2016","journal-title":"J Anal Methods Chem"},{"key":"10.1016\/j.pharma.2026.07.008_bib0225","doi-asserted-by":"crossref","first-page":"118795","DOI":"10.1016\/j.microc.2026.118795","article-title":"Breaking barriers in brexpiprazole bioequivalence: a first-in-human UPLC-MS\/MS approach to circumvent clinical sampling constraints","volume":"227","author":"Wadie","year":"2026","journal-title":"Microchem J"},{"issue":"1","key":"10.1016\/j.pharma.2026.07.008_bib0230","doi-asserted-by":"crossref","first-page":"e70079","DOI":"10.1002\/ansa.70079","article-title":"A novel ultra-performance liquid chromatography-electrospray ionisation-tandem mass spectrometry method for quantification of imeglimin in human plasma: application to a bioequivalence study","volume":"7","author":"Wadie","year":"2026","journal-title":"Anal Sci Adv"},{"key":"10.1016\/j.pharma.2026.07.008_bib0235","doi-asserted-by":"crossref","first-page":"124576","DOI":"10.1016\/j.jchromb.2025.124576","article-title":"A novel ultra-sensitive LC-MS\/MS method for determination of elobixibat in human plasma; application to a bioequivalence study on healthy volunteers","volume":"1257","author":"Rezk","year":"2025","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharma.2026.07.008_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2014.05.005","article-title":"Development, optimization and validation of a highly sensitive UPLC-ESI-MS\/MS method for simultaneous quantification of amlodipine, benazeprile and benazeprilat in human plasma: application to a bioequivalence study","volume":"98","author":"Rezk","year":"2014","journal-title":"J Pharm Biomed Anal"},{"issue":"9","key":"10.1016\/j.pharma.2026.07.008_bib0245","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bmc.3690","article-title":"Novel and sensitive UPLC-MS\/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study","volume":"30","author":"Rezk","year":"2016","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"10.1016\/j.pharma.2026.07.008_bib0250","doi-asserted-by":"crossref","first-page":"e5048","DOI":"10.1002\/bmc.5048","article-title":"Determination of amlodipine, indapamide and perindopril in human plasma by a novel LC-MS\/MS method: application to a bioequivalence study","volume":"35","author":"Rezk","year":"2021","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.pharma.2026.07.008_bib0255","doi-asserted-by":"crossref","first-page":"115165","DOI":"10.1016\/j.jpba.2022.115165","article-title":"LC-MS\/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: application to a human pharmacokinetic study","volume":"223","author":"Gouda","year":"2023","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"10.1016\/j.pharma.2026.07.008_bib0260","doi-asserted-by":"crossref","first-page":"e4224","DOI":"10.1002\/bmc.4224","article-title":"Quantification of amlodipine and atorvastatin in human plasma by UPLC-MS\/MS method and its application to a bioequivalence study","volume":"32","author":"Rezk","year":"2018","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.pharma.2026.07.008_bib0265","doi-asserted-by":"crossref","first-page":"124836","DOI":"10.1016\/j.jchromb.2025.124836","article-title":"Development and validation of an LC\u2013MS\/MS method for tirzepatide in rat plasma for application to a pharmacokinetic study","volume":"1268","author":"Choi","year":"2026","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.pharma.2026.07.008_bib0270","doi-asserted-by":"crossref","first-page":"e26209","DOI":"10.1016\/j.heliyon.2024.e26209","article-title":"A sensitive and specific LC\u2013MS\/MS method for determination of a novel antihypertensive peptide FR-6 in rat plasma and pharmacokinetic study","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.pharma.2026.07.008_bib0275","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s10787-023-01244-7","article-title":"Diosgenin, a steroidal sapogenin, arrests arthritis through modulation of inflammatory cytokines and oxidative stress biomarkers in Wistar rats","volume":"31","author":"Javed","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharma.2026.07.008_bib0280","doi-asserted-by":"crossref","first-page":"629272","DOI":"10.3389\/fphar.2021.629272","article-title":"Pharmacokinetic profile and oral bioavailability of diosgenin, charantin, and hydroxychalcone from a polyherbal formulation","volume":"12","author":"Salunkhe","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092600115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345092600115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:56:02Z","timestamp":1786996562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000345092600115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S000345092600115X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.07.008","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A highly-sensitive and selective LC\u2013MS\/MS platform for quantitative determination of diosgenin in mice plasma with comprehensive bioanalytical validation and pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}